CCO Expert Recap

Advances in HCV Treatment: 2006

Source: 2006 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

CCO Expert Recap: HCV Treatment Update

Faculty:
Mitchell L. Shiffman, MD

CME CREDIT INFORMATION

Release Date: 12/12/06

Expiration Date: 12/11/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Mitchell L. Shiffman, MD, reviews the most important data on hepatitis C from the Boston meeting and discusses the implications for clinical practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the clinical implications of new diagnostic tools in choosing when to initiate HCV therapy
Recount clinical trial data from studies evaluating the management of difficult-to-treat patient cohorts with chronic hepatitis C
Describe the clinical implications of new therapies on the management of patients with chronic hepatitis C

Slideset

CCO Slideset – HCV Treatment Update

CCO’s slides summarizing important new data presented at medical conferences, printed in journal articles, or those used by speakers in live programs (satellites, dinner meetings, or Webcasts) are made available to members free of charge to download for use in their own talks.

Format: Microsoft PowerPoint (.ppt) | File size: 489 KB